Literature DB >> 24815216

The daily burden of acute kidney injury: a survey of U.S. nephrologists on World Kidney Day.

Jay L Koyner1, Jorge Cerdá2, Stuart L Goldstein3, Bertrand L Jaber4, Kathleen D Liu5, Judy A Shea6, Sarah Faubel7.   

Abstract

BACKGROUND: World Kidney Day 2013 focused on raising awareness of the impact and consequences of acute kidney injury (AKI). Although many studies have examined rates of AKI in hospitalized patients, we were interested in the impact of AKI on the workload of nephrologists. STUDY
DESIGN: Cross-sectional forced-choice internet-based survey. SETTING & PARTICIPANTS: 598 survey respondents who were US-based nephrologist members of the American Society of Nephrology. OUTCOMES: Numbers of inpatients and outpatients seen on World Kidney Day 2013 for the management of AKI or other conditions (and specifically in-hospital renal replacement therapies [RRTs]), based on self-report of number/percentage of patients seen on World Kidney Day and in the prior year.
RESULTS: Of 598 physician respondents (response rate, 12%), 310 saw patients in the hospital on World Kidney Day. Of 3,285 patients seen by respondents, 1,500 were seen for AKI (46%); 1,233, for end-stage renal disease (37%); and 552, for non-AKI/end-stage renal disease-related problems (17%). Of patients with AKI, 688 (46%) were in the intensive care unit and 415 (28%) received RRT. Intermittent hemodialysis was performed in 315 patients (76%) who received RRT. Delivered dialysis dose was quantified in only 48 (15%) of those receiving intermittent hemodialysis. 260 respondents saw 2,380 patients in the ambulatory setting, of whom 207 (9%) were seen for follow-up of AKI. LIMITATIONS: There was a low response rate to the survey. Numbers of patients were self-reported.
CONCLUSIONS: This is the first physician survey examining the care of patients and impact of AKI on current in-hospital and ambulatory nephrology practices. In our sample, AKI was the most common reason for in-hospital nephrology consultation. Furthermore, our findings point to significant areas in which improvement is needed, including inadequate quantification of dialysis delivered dose. Finally, our survey highlights that AKI is a major public health issue.
Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury (AKI); World Kidney Day; dialysis; dialysis dosing; epidemiology; nephrology; public health; survey; workload

Mesh:

Year:  2014        PMID: 24815216     DOI: 10.1053/j.ajkd.2014.03.018

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  22 in total

1.  Development of a Multicenter Ward-Based AKI Prediction Model.

Authors:  Jay L Koyner; Richa Adhikari; Dana P Edelson; Matthew M Churpek
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-15       Impact factor: 8.237

2.  Post-Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression: The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study.

Authors:  Chi-Yuan Hsu; Vernon M Chinchilli; Steven Coca; Prasad Devarajan; Nasrollah Ghahramani; Alan S Go; Raymond K Hsu; T Alp Ikizler; James Kaufman; Kathleen D Liu; Chirag R Parikh; W Brian Reeves; Mark Wurfel; Michael Zappitelli; Paul L Kimmel; Edward D Siew
Journal:  JAMA Intern Med       Date:  2020-03-01       Impact factor: 21.873

3.  Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.

Authors:  Jay L Koyner; Danielle L Davison; Ermira Brasha-Mitchell; Divya M Chalikonda; John M Arthur; Andrew D Shaw; James A Tumlin; Sharon A Trevino; Michael R Bennett; Paul L Kimmel; Michael G Seneff; Lakhmir S Chawla
Journal:  J Am Soc Nephrol       Date:  2015-02-05       Impact factor: 10.121

Review 4.  Mechanisms and mediators of lung injury after acute kidney injury.

Authors:  Sarah Faubel; Charles L Edelstein
Journal:  Nat Rev Nephrol       Date:  2015-10-06       Impact factor: 28.314

5.  Reconfiguring Health Care Delivery to Improve AKI Outcomes.

Authors:  Jay L Koyner
Journal:  Clin J Am Soc Nephrol       Date:  2017-07-20       Impact factor: 8.237

6.  Continuous Renal Replacement Therapy Dosing in Critically Ill Patients: A Quality Improvement Initiative.

Authors:  Benjamin R Griffin; Amanda Thomson; Mark Yoder; Isaiah Francis; Sophia Ambruso; Adam Bregman; Michelle Feller; Shannon Johnson-Bortolotto; Christine King; Deborah Bonnes; Lisa Dufficy; Chaorong Wu; Anip Bansal; Darlene Tad-Y; Sarah Faubel; Diana Jalal
Journal:  Am J Kidney Dis       Date:  2019-09-17       Impact factor: 8.860

7.  Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.

Authors:  Anitha Vijayan; Sarah Faubel; David J Askenazi; Jorge Cerda; William H Fissell; Michael Heung; Benjamin D Humphreys; Jay L Koyner; Kathleen D Liu; Girish Mour; Thomas D Nolin; Azra Bihorac
Journal:  Am J Kidney Dis       Date:  2016-03-04       Impact factor: 8.860

Review 8.  CD39-adenosinergic axis in renal pathophysiology and therapeutics.

Authors:  Bellamkonda K Kishore; Simon C Robson; Karen M Dwyer
Journal:  Purinergic Signal       Date:  2018-01-13       Impact factor: 3.765

9.  AKI!Now Initiative: Recommendations for Awareness, Recognition, and Management of AKI.

Authors:  Kathleen D Liu; Stuart L Goldstein; Anitha Vijayan; Chirag R Parikh; Kianoush Kashani; Mark D Okusa; Anupam Agarwal; Jorge Cerdá
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-21       Impact factor: 8.237

10.  Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.

Authors:  Hiraku Tsujimoto; Yasushi Tsujimoto; Yukihiko Nakata; Tomoko Fujii; Sei Takahashi; Mai Akazawa; Yuki Kataoka
Journal:  Cochrane Database Syst Rev       Date:  2020-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.